EXACT Therapeutics AS (OSL: EXTX)
Norway
· Delayed Price · Currency is NOK 3.400
-0.060 (-1.73%)
At close: Jan 17, 2025
EXACT Therapeutics AS Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Cash & Equivalents | 15.8 | 46.43 | 69.39 | 82.91 | 139.22 | 23.75 | Upgrade
|
| Short-Term Investments | - | - | - | 20.78 | 20.5 | 21.8 | Upgrade
|
| Cash & Short-Term Investments | 15.8 | 46.43 | 69.39 | 103.69 | 159.72 | 45.55 | Upgrade
|
| Cash Growth | -59.62% | -33.09% | -33.08% | -35.08% | 250.62% | -23.06% | Upgrade
|
| Other Receivables | 10.98 | 9.47 | 8.14 | 7.61 | 5.99 | 5.09 | Upgrade
|
| Receivables | 10.98 | 9.47 | 8.14 | 7.61 | 5.99 | 5.09 | Upgrade
|
| Total Current Assets | 26.78 | 55.9 | 77.53 | 111.3 | 165.71 | 50.65 | Upgrade
|
| Property, Plant & Equipment | 4.58 | 5.42 | 4.97 | 6.33 | 4.52 | 1.46 | Upgrade
|
| Other Long-Term Assets | 0 | 0 | 0 | - | - | - | Upgrade
|
| Total Assets | 31.36 | 61.32 | 82.51 | 117.63 | 170.23 | 52.1 | Upgrade
|
| Accounts Payable | 7.43 | 7.21 | 9.55 | 3.18 | 1.81 | 3.34 | Upgrade
|
| Accrued Expenses | 4.23 | 6.17 | 4.71 | 6.33 | 8.25 | 5.49 | Upgrade
|
| Current Portion of Leases | 0.35 | 0.55 | 0.5 | 0.36 | 0.04 | 0.15 | Upgrade
|
| Other Current Liabilities | 1.26 | 1.56 | 1.37 | 0.66 | 0.49 | 0.85 | Upgrade
|
| Total Current Liabilities | 13.27 | 15.49 | 16.13 | 10.53 | 10.58 | 9.83 | Upgrade
|
| Long-Term Leases | 0.57 | 0.65 | 1.19 | 1.35 | - | 0.04 | Upgrade
|
| Other Long-Term Liabilities | 0.09 | 0.08 | 0.08 | 0 | - | - | Upgrade
|
| Total Liabilities | 13.92 | 16.22 | 17.4 | 11.89 | 10.58 | 9.87 | Upgrade
|
| Common Stock | 0.13 | 0.13 | 0.12 | 0.12 | 0.12 | 0.09 | Upgrade
|
| Additional Paid-In Capital | 0.14 | 29.44 | 93.52 | 215.63 | 215.14 | 72.44 | Upgrade
|
| Retained Earnings | - | - | -40.1 | -122.01 | -63.45 | -30.29 | Upgrade
|
| Comprehensive Income & Other | 17.17 | 15.53 | 11.57 | 12.01 | 7.85 | - | Upgrade
|
| Shareholders' Equity | 17.44 | 45.1 | 65.11 | 105.74 | 159.65 | 42.24 | Upgrade
|
| Total Liabilities & Equity | 31.36 | 61.32 | 82.51 | 117.63 | 170.23 | 52.1 | Upgrade
|
| Total Debt | 0.92 | 1.2 | 1.69 | 1.71 | 0.04 | 0.18 | Upgrade
|
| Net Cash (Debt) | 14.88 | 45.23 | 67.7 | 101.97 | 159.69 | 45.37 | Upgrade
|
| Net Cash Growth | -60.52% | -33.19% | -33.61% | -36.14% | 251.96% | -23.37% | Upgrade
|
| Net Cash Per Share | 0.45 | 1.41 | 2.26 | 3.40 | 5.33 | 2.42 | Upgrade
|
| Filing Date Shares Outstanding | 32.08 | 32.08 | 30 | 29.99 | 29.97 | 29.97 | Upgrade
|
| Total Common Shares Outstanding | 32.08 | 32.08 | 30 | 29.99 | 29.97 | 29.97 | Upgrade
|
| Working Capital | 13.51 | 40.41 | 61.41 | 100.76 | 155.14 | 40.82 | Upgrade
|
| Book Value Per Share | 0.54 | 1.41 | 2.17 | 3.53 | 5.33 | 1.41 | Upgrade
|
| Tangible Book Value | 17.44 | 45.1 | 65.11 | 105.74 | 159.65 | 42.24 | Upgrade
|
| Tangible Book Value Per Share | 0.54 | 1.41 | 2.17 | 3.53 | 5.33 | 1.41 | Upgrade
|
| Machinery | - | 11.28 | 8.22 | 8.02 | 6.39 | 2.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.